Download PDF
Fortschr Neurol Psychiatr 2012; 80(12): 720-731
DOI: 10.1055/s-0032-1325607
Fort- und Weiterbildung
© Georg Thieme Verlag KG Stuttgart · New York

Elektrokonvulsionstherapie – Indikationsstellung und Durchführung bei pharmakotherapieresistenten psychiatrischen Erkrankungen

Electroconvulsive Therapy – Indications and Practical Use for Pharmacotherapy Resistant Depressive Disorders
T. C. Baghai
,
M. Lieb
,
R. Rupprecht
Further Information

Publication History

Publication Date:
10 December 2012 (online)

    Permissions and Reprints

Lernziele

Der Artikel gibt den Lesern einen klinisch orientierten Überblick über den möglichen Einsatz der Elektrokonvulsionstherapie (EKT) bei schwierig zu behandelnden und pharmakotherapieresistenten depressiven Störungen. Es wird umfassend über Indikationsstellung, Wirksamkeit und Verträglichkeit inkl. der möglichen unerwünschten Wirkungen sowie über neue wissenschaftliche Entwicklungen informiert. Aufgrund der heute immer noch vorhandenen Stigmatisierung des Verfahrens wird zudem kurz über die Integration der EKT in die moderne Medizin und über die Anwendung des Therapieverfahrens in Therapiealgorithmen zur effektiven Behandlung depressiver Störungen informiert.

 

  • Literatur

  • 1 Diazgranados N, Ibrahim L, Brutsche NE et al. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 2010; 67 (08) 793-802
    CrossrefPubMedGoogle Scholar
  • 2 Zarate Jr CA, Singh JB, Carlson PJ et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006; 63 (08) 856-864
    CrossrefPubMedGoogle Scholar
  • 3 Mathew SJ, Shah A, Lapidus K et al. Ketamine for treatment-resistant unipolar depression: current evidence. CNS Drugs 2012; 26 (03) 189-204
    CrossrefPubMedGoogle Scholar
  • 4 World Health Organization. WHO resource book on mental health, human rights and legislation. 2005
    PubMedGoogle Scholar
  • 5 Chanpattana W, Kramer BA, Kunigiri G et al. A survey of the practice of electroconvulsive therapy in Asia. J ECT 2010; 26 (01) 5-10
    PubMedGoogle Scholar
  • 6 Leiknes KA, Jarosh-von SL, Hoie B. Contemporary use and practice of electroconvulsive therapy worldwide. Brain Behav 2012; 2 (03) 283-344
    CrossrefPubMedGoogle Scholar
  • 7 Scharfetter J, Frey R, Kasper S. Biologische Grundlagen der Elektrokonvulsionstherapie. In: Baghai TC, Frey R, Kasper S, et al. (Hrsg) Elektrokonvulsionstherapie – Klinische und wissenschaftliche Aspekte. Wien, New York: Springer; 2004: 87-105
    CrossrefGoogle Scholar
  • 8 Holtzmann J, Polosan M, Baro P et al. ECT: from neuronal plasticity to mechanisms underlying antidepressant medication effect. Encephale 2007; 33 (04) 572-578
    CrossrefPubMedGoogle Scholar
  • 9 Taylor SM. Electroconvulsive therapy, brain-derived neurotrophic factor, and possible neurorestorative benefit of the clinical application of electroconvulsive therapy. J ECT 2008; 24 (02) 160-165
    CrossrefPubMedGoogle Scholar
  • 10 Gedge L, Beaudoin A, Lazowski L et al. Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression. Front Psychiatry 2012; 3: 12
    PubMedGoogle Scholar
  • 11 Loh N, Nickl-Jockschat T, Sheldrick AJ et al. Accessibility, standards and challenges of electroconvulsive therapy in Western industrialized countries: A German example. World J Biol Psychiatry 2012; DOI: 10.3109/15622975.2012.665176.
    PubMedGoogle Scholar
  • 12 Bustin J, Rapoport MJ, Krishna M et al. Are patients’ attitudes towards and knowledge of electroconvulsive therapy transcultural? A multi-national pilot study. Int J Geriatr Psychiatry 2008; 23 (05) 497-503
    CrossrefPubMedGoogle Scholar
  • 13 Rajagopal R, Chakrabarti S, Grover S et al. Knowledge, experience & attitudes concerning electroconvulsive therapy among patients & their relatives. Indian J Med Res 2012; 135: 201-210
    PubMedGoogle Scholar
  • 14 Gangadhar BN, Kapur RL, Kalyanasundaram S. Comparison of electroconvulsive therapy with imipramine in endogenous depression: a double blind study. Br J Psychiatry 1982; 141: 367-371
    CrossrefPubMedGoogle Scholar
  • 15 Rothschild AJ. Management of psychotic, treatment-resistant depression. Psychiatr Clin North Am 1996; 19 (02) 237-252
    CrossrefPubMedGoogle Scholar
  • 16 Sauer H, Lauter H. Electroconvulsive therapy. II. Indications, contraindications and therapeutic technics of electroconvulsive therapy. Nervenarzt 1987; 58 (04) 210-218
    PubMedGoogle Scholar
  • 17 Prudic J, Haskett RF, Mulsant B et al. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry 1996; 153 (08) 985-992
    PubMedGoogle Scholar
  • 18 Sackeim HA. The definition and meaning of treatment-resistant depression. J Clin Psychiatry 2001; 62 (Suppl. 16) 10-17
    PubMedGoogle Scholar
  • 19 Sartorius N, Baghai TC, Baldwin DS et al. Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence. Int J Neuropsychopharmacol 2007; 10 (Suppl. 01) S1-S207
    CrossrefPubMedGoogle Scholar
  • 20 Stassen HH, Angst J. Delayed Onset of Action of Antidepressants – Fact or Fiction?. CNS Drugs 1998; 9 (03) 177-184
    CrossrefPubMedGoogle Scholar
  • 21 Szegedi A, Jansen WT, van Willigenburg AP et al. Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients. J Clin Psychiatry 2009; 70 (03) 344-353
    CrossrefPubMedGoogle Scholar
  • 22 Folkerts HW, Michael N, Tolle R et al. Electroconvulsive therapy vs. paroxetine in treatment-resistant depression – a randomized study. Acta Psychiatr Scand 1997; 96 (05) 334-342
    CrossrefPubMedGoogle Scholar
  • 23 Flint AJ, Rifat SL. The treatment of psychotic depression in later life: a comparison of pharmacotherapy and ECT. Int J Geriatr Psychiatry 1998; 13 (01) 23-28
    CrossrefPubMedGoogle Scholar
  • 24 McCall WV. Electroconvulsive therapy in the era of modern psychopharmacology. Int J Neuropsychopharmacol 2001; 4 (03) 315-324
    PubMedGoogle Scholar
  • 25 Rabheru K. Maintenance electroconvulsive therapy (M-ECT) after acute response: examining the evidence for who, what, when, and how?. J ECT 2012; 28 (01) 39-47
    CrossrefPubMedGoogle Scholar
  • 26 Frey R, Schreinzer D, Heiden A et al. Use of electroconvulsive therapy in psychiatry. Nervenarzt 2001; 72 (09) 661-676
    CrossrefPubMedGoogle Scholar
  • 27 Pfennig A, Bschor T, Baghai T et al. S3 guidelines on diagnostics and therapy of bipolar disorders: development process and essential recommendations. Nervenarzt 2012; 83 (05) 568-586
    CrossrefPubMedGoogle Scholar
  • 28 Grunze H, Schlosser S, Walden J. New perspectives in the acute treatment of bipolar depression. World J Biol Psychiatry 2000; 1 (03) 129-136
    CrossrefPubMedGoogle Scholar
  • 29 DeQuardo JR, Tandon R. Concurrent lithium therapy prevents ECT-induced switch to mania. J Clin Psychiatry 1988; 49 (04) 167-168
    PubMedGoogle Scholar
  • 30 Aarre TF, Bugge P. ECT for patients taking lamotrigine. Eur Psychiatry 2002; 17 (Suppl. 01) 135
    PubMedGoogle Scholar
  • 31 Zarate Jr CA, Tohen M, Baraibar G. Combined valproate or carbamazepine and electroconvulsive therapy. Ann Clin Psychiatry 1997; 9 (01) 19-25
    PubMedGoogle Scholar
  • 32 Weiner RD, Coffey CE, Folk J et al. The Practice of Electroconvulsive Therapy. 2nd ed. Washington: American Psychiatric Association; 2001
    Google Scholar
  • 33 Greenblatt M, Grosser GH, Wechsler HA. Differential response of hospitalized depressed patients in somatic therapy. Am J Psychiatry 1964; 120: 935-943
    PubMedGoogle Scholar
  • 34 McDonald IM, Perkins M, Marjerrison G et al. A controlled comparison of amitriptyline and electroconvulsive therapy in the treatment of depression. Am J Psychiatry 1966; 122 (12) 1427-1431
    PubMedGoogle Scholar
  • 35 Janicak PG, Davis JM, Gibbons RD et al. Efficacy of ECT: a meta-analysis. Am J Psychiatry 1985; 142 (03) 297-302
    PubMedGoogle Scholar
  • 36 Rifkin A. ECT versus tricyclic antidepressants in depression: a review of the evidence. J Clin Psychiatry 1988; 49 (01) 3-7
    PubMedGoogle Scholar
  • 37 Prudic J, Sackeim HA, Devanand DP. Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res 1990; 31 (03) 287-296
    CrossrefPubMedGoogle Scholar
  • 38 Dinan TG, Barry S. A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic nonresponders. Acta Psychiatr Scand 1989; 80 (01) 97-100
    CrossrefPubMedGoogle Scholar
  • 39 Sonawalla SB, Fava M. Severe depression: is there a best approach?. CNS Drugs 2001; 15 (10) 765-776
    CrossrefPubMedGoogle Scholar
  • 40 Kopecek M, Cerna L, Sulak J et al. Depressed patients perception of the efficacy of electroconvulsive therapy and venlafaxine therapy. Neuro Endocrinol Lett 2007; 28 (06) 889-894
    PubMedGoogle Scholar
  • 41 Baghai TC, Marcuse A, Brosch M et al. The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World Journal of Biological Psychiatry In press
    PubMedGoogle Scholar
  • 42 Sackeim HA, Prudic J, Devanand DP et al. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 2000; 57 (05) 425-434
    CrossrefPubMedGoogle Scholar
  • 43 Quitkin FM, McGrath PJ, Stewart JW et al. Can the effects of antidepressants be observed in the first two weeks of treatment?. Neuropsychopharmacology 1996; 15 (04) 390-394
    CrossrefPubMedGoogle Scholar
  • 44 Nobler MS, Sackeim HA, Moeller JR et al. Quantifying the speed of symptomatic improvement with electroconvulsive therapy: comparison of alternative statistical methods. Convuls Ther 1997; 13 (04) 208-221
    PubMedGoogle Scholar
  • 45 Nothdurfter C, Eser D, Schule C et al. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World J Biol Psychiatry 2006; 7 (03) 162-170
    CrossrefPubMedGoogle Scholar
  • 46 Lehman AF, Lieberman JA, Dixon LB et al. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry 2004; 161 (Suppl. 02) 1-56
    Google Scholar
  • 47 American Psychiatric Association. The Practice of ECT: Recommendations for Treatment, Training and Privileging. Convuls Ther 1990; 6 (02) 85-120
    PubMedGoogle Scholar
  • 48 Lehnhardt FG, Konkol C, Kuhn J. Use of ECT in Drug-Refractory Schizophrenia – A Survey of the Current Literature. Fortschr Neurol Psychiatr 2012; 80: 501-511
    Article in Thieme ConnectPubMedGoogle Scholar
  • 49 Beale MD, Kellner CH, Pritchett JT et al. ECT for OCD. J Clin Psychiatry 1995; 56 (02) 81-82
    PubMedGoogle Scholar
  • 50 Rabheru K, Persad E. A review of continuation and maintenance electroconvulsive therapy. Can J Psychiatry 1997; 42 (05) 476-484
    PubMedGoogle Scholar
  • 51 Sareen J, Enns MW, Guertin JE. The impact of clinically diagnosed personality disorders on acute and one-year outcomes of electroconvulsive therapy. J ECT 2000; 16 (01) 43-51
    CrossrefPubMedGoogle Scholar
  • 52 Zorumski CF, Rutherford JL, Burke WJ et al. ECT in primary and secondary depression. J Clin Psychiatry 1986; 47 (06) 298-300
    PubMedGoogle Scholar
  • 53 Murray GB, Shea V, Conn DK. Electroconvulsive therapy for poststroke depression. J Clin Psychiatry 1986; 47 (05) 258-260
    PubMedGoogle Scholar
  • 54 Hackett ML, Anderson CS, House A et al. Interventions for treating depression after stroke. Cochrane Database Syst Rev 2008; 4: CD003437
    PubMedGoogle Scholar
  • 55 Oudman E. Is electroconvulsive therapy (ECT) effective and safe for treatment of depression in dementia? A short review. J ECT 2012; 28 (01) 34-38
    CrossrefPubMedGoogle Scholar
  • 56 Abrams R. Electroconvulsive Therapy. 4th ed. Oxford, New York: Oxford University Press; 2002
    Google Scholar
  • 57 Baghai TC, Eser D, Schüle C et al. Elektrokonvulsionstherapie bei depressiven Störungen. Journal für Neurologie, Neurochirurgie und Psychiatrie 2005; 4: 20-28
    PubMedGoogle Scholar
  • 58 Abrams R. The mortality rate with ECT. Convuls Ther 1997; 13 (03) 125-127
    PubMedGoogle Scholar
  • 59 Shiwach RS, Reid WH, Carmody TJ. An analysis of reported deaths following electroconvulsive therapy in Texas, 1993–1998. Psychiatr Serv 2001; 52 (08) 1095-1097
    CrossrefPubMedGoogle Scholar
  • 60 Dersch R, Zwernemann S, Voderholzer U. Partial status epilepticus after electroconvulsive therapy and medical treatment with bupropion. Pharmacopsychiatry 2011; 44 (07) 344-346
    Article in Thieme ConnectPubMedGoogle Scholar
  • 61 Kamel H, Cornes SB, Hegde M et al. Electroconvulsive therapy for refractory status epilepticus: a case series. Neurocrit Care 2010; 12 (02) 204-210
    CrossrefPubMedGoogle Scholar
  • 62 Pogarell O, Ehrentraut S, Ruther T et al. Prolonged confusional state following electroconvulsive therapy – diagnostic clues from serial electroencephalography. Pharmacopsychiatry 2005; 38 (06) 316-320
    Article in Thieme ConnectPubMedGoogle Scholar
  • 63 Fink M. Interseizure EEG Slowing after ECT is not NCSE. Pharmacopsychiatry 2006; 39 (03) 119
    Article in Thieme ConnectPubMedGoogle Scholar
  • 64 Reimherr FW, Hodges MR, Hill GE et al. Prolongation of muscle relaxant effects by lithium carbonate. Am J Psychiatry 1977; 134 (02) 205-206
    PubMedGoogle Scholar
  • 65 Markowitz JS, Kellner CH, DeVane CL et al. Intranasal sumatriptan in post-ECT headache: results of an open-label trial. J ECT 2001; 17 (04) 280-283
    CrossrefPubMedGoogle Scholar
  • 66 Calev A, Gaudino EA, Squires NK et al. ECT and non-memory cognition: a review. Br J Clin Psychol 1995; 34 (04) 505-515
    CrossrefPubMedGoogle Scholar
  • 67 Lisanby SH, Maddox JH, Prudic J et al. The effects of electroconvulsive therapy on memory of autobiographical and public events. Arch Gen Psychiatry 2000; 57 (06) 581-590
    CrossrefPubMedGoogle Scholar
  • 68 Semkovska M, McLoughlin DM. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychiatry 2010; 68 (06) 568-577
    CrossrefPubMedGoogle Scholar
  • 69 Devanand DP, Fitzsimons L, Prudic J et al. Subjective side effects during electroconvulsive therapy. Convuls Ther 1995; 11 (04) 232-240
    PubMedGoogle Scholar
  • 70 Calev A, Nigal D, Shapira B et al. Early and long-term effects of electroconvulsive therapy and depression on memory and other cognitive functions. J Nerv Ment Dis 1991; 179 (09) 526-533
    CrossrefPubMedGoogle Scholar
  • 71 Krystal AD, Coffey CE. Neuropsychiatric considerations in the use of electroconvulsive therapy. J Neuropsychiatry Clin Neurosci 1997; 9 (02) 283-292
    PubMedGoogle Scholar
  • 72 Delva NJ, Brunet D, Hawken ER et al. Electrical dose and seizure threshold: relations to clinical outcome and cognitive effects in bifrontal, bitemporal, and right unilateral ECT. J ECT 2000; 16 (04) 361-369
    CrossrefPubMedGoogle Scholar
  • 73 Ng C, Schweitzer I, Alexopoulos P et al. Efficacy and cognitive effects of right unilateral electroconvulsive therapy. J ECT 2000; 16 (04) 370-379
    CrossrefPubMedGoogle Scholar
  • 74 Cohen D, Taieb O, Flament M et al. Absence of cognitive impairment at long-term follow-up in adolescents treated with ECT for severe mood disorder. Am J Psychiatry 2000; 157 (03) 460-462
    CrossrefPubMedGoogle Scholar
  • 75 Pettinati HM, Bonner KM. Cognitive functioning in depressed geriatric patients with a history of ECT. Am J Psychiatry 1984; 141 (01) 49-52
    PubMedGoogle Scholar
  • 76 Agelink MW, Andrich J, Postert T et al. Relation between electroconvulsive therapy, cognitive side effects, neuron specific enolase, and protein S-100. J Neurol Neurosurg Psychiatry 2001; 71 (03) 394-396
    CrossrefPubMedGoogle Scholar
  • 77 ECT review group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 2003; 361 (9360) 799-808
    CrossrefPubMedGoogle Scholar
  • 78 Sackeim HA, Prudic J, Devanand DP et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med 1993; 328 (12) 839-846
    CrossrefPubMedGoogle Scholar
  • 79 Ostroff R, Gonzales M, Sanacora G. Antidepressant effect of ketamine during ECT. Am J Psychiatry 2005; 162 (07) 1385-1386
    CrossrefPubMedGoogle Scholar
  • 80 Okamoto N, Nakai T, Sakamoto K et al. Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: comparing ketamine and propofol anesthesia. J ECT 2010; 26 (03) 223-227
    PubMedGoogle Scholar
  • 81 Viswanath B, Narayanaswamy JC, Thirthalli J et al. Effectiveness of Bifrontal ECT in Practice: A Comparison with Bitemporal ECT. Indian J Psychol Med 2011; 33 (01) 66-70
    CrossrefPubMedGoogle Scholar
  • 82 Eschweiler GW, Vonthein R, Bode R et al. Clinical efficacy and cognitive side effects of bifrontal versus right unilateral electroconvulsive therapy (ECT): a short-term randomised controlled trial in pharmaco-resistant major depression. J Affect Disord 2007; 101 (01) 149-157
    CrossrefPubMedGoogle Scholar
  • 83 Sienaert P. Bifrontal, bitemporal and right unilateral ECT electrode placement are similarly effective for reducing depressive symptoms. Evid Based Ment Health 2010; 13 (03) 85
    CrossrefPubMedGoogle Scholar
  • 84 Quante A, Luborzewski A, Brakemeier EL et al. Effects of 3 different stimulus intensities of ultrabrief stimuli in right unilateral electroconvulsive therapy in major depression: a randomized, double-blind pilot study. J Psychiatr Res 2011; 45 (02) 174-178
    CrossrefPubMedGoogle Scholar